DP-VPA

N/A

Report date: 2022/06/27 20:00:35
NME

Base Information

Drug NameDP-VPA
Drug Alias NameDP-VPASPD-421
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsMigraine DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsraelMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesD-Pharm Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesD-Pharm Ltd
Active IndicationsMigraine Disorders
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksDrugBank